These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy. Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375 [TBL] [Abstract][Full Text] [Related]
15. [Blood pressure goal and antihypertensive therapy in chronic kidney disease]. Rump LC Dtsch Med Wochenschr; 2014 Nov; 139(48):2453-7. PubMed ID: 25409404 [No Abstract] [Full Text] [Related]
16. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091 [TBL] [Abstract][Full Text] [Related]
17. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study. Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T; Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719 [TBL] [Abstract][Full Text] [Related]
18. Endothelin receptor antagonists and their developing role in cardiovascular therapeutics. Dupuis J Can J Cardiol; 2000 Jul; 16(7):903-10. PubMed ID: 10934309 [TBL] [Abstract][Full Text] [Related]
19. Should diuretics always be included as initial antihypertensive management in early-stage CKD? Segura J; Ruilope LM Curr Opin Nephrol Hypertens; 2009 Sep; 18(5):392-6. PubMed ID: 19561495 [TBL] [Abstract][Full Text] [Related]
20. Blood pressure response to type A endothelin receptor antagonism in human obesity and diabetes mellitus. Han KA; Lteif AA; Mather KJ J Hum Hypertens; 2006 Oct; 20(10):798-800. PubMed ID: 16855627 [No Abstract] [Full Text] [Related] [Next] [New Search]